Related Experiment Video
Updated: Jul 6, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Using Quality Improvement Methodology to Inform Safe Implementation of Propofol Procedural Sedation in a Pediatric
Alexandria Wiersma1, Nikita Habermehl, Rebecca Helmuth
1Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Insights
Quality improvement methodology safely introduced propofol for pediatric procedural sedation in emergency departments. Propofol use reduced sedation and length of stay for selected patients, with low serious adverse events.
Area of Science:
- Pediatric Emergency Medicine
- Quality Improvement Science
- Pharmacology
Background:
- Procedural sedation in pediatric emergency departments (EDs) is common.
- Optimizing sedation practices is crucial for patient flow and safety.
- Propofol offers potential benefits but requires careful implementation.
Purpose of the Study:
- To implement propofol for pediatric procedural sedation across a multisite ED system using quality improvement (QI) methods.
- To evaluate the impact of propofol on sedation duration, length of stay (LOS), and serious adverse events (SAEs).
Main Methods:
- A QI initiative employed the Define-Measure-Analyze-Improve-Control (DMAIC) framework across 4 pediatric EDs.
- A standardized propofol sedation protocol was developed and implemented for short procedures in low-risk patients.
- Interventions included protocol development, multidisciplinary education, simulation, and EMR order set modifications.
Main Results:
- Propofol sedation was significantly shorter than ketamine sedation (18-24 min vs. 33-52 min; P < 0.001).
- ED LOS was shorter for propofol sedations at primary and secondary sites.
- Serious adverse event (SAE) rates remained low and stable (2.6% for propofol-associated SAEs).
Conclusions:
- QI methodology facilitated the safe and feasible implementation of propofol in a multisite pediatric ED system.
- Propofol use, within a defined scope, shortened sedation length and LOS for selected pediatric patients.
- This study provides a reproducible framework for implementing propofol sedation in similar settings.
Objectives:
This study used quality improvement (QI) methodology to safely introduce propofol for use in pediatric procedural sedation across a multisite emergency department (ED) system and to evaluate its impact on length of sedation, length of stay (LOS), and serious adverse events (SAEs).
Methods:
We conducted a QI initiative across 4 pediatric EDs within a quaternary children's hospital network. A multidisciplinary team used the Define-Measure-Analyze-Improve-Control (DMAIC) framework to develop and implement a standardized propofol sedation protocol for short procedures in low-risk patients. Interventions included protocol development, multidisciplinary education, simulation training, electronic medical record (EMR) order set modifications, and phased site rollout. The primary outcome measure was median length of sedation. Secondary outcomes included ED LOS and proportion of sedations using propofol. The balancing measure was airway-related SAEs. All outcomes were analyzed using statistical process control charts and nonparametric testing.
Results:
During the study period, 2368 children underwent procedural sedation with ketamine (2251) or propofol (117). Median length of sedation for all sedations showed no special cause variation. However, propofol sedation duration was significantly shorter than ketamine across sites (18 to 24 vs. 33 to 52 min; P < 0.001). At the primary site, propofol sedation was shorter than ketamine sedations performed within propofol scope (23 vs. 32.5 min; P < 0.001). ED LOS was shorter for propofol sedations at the primary and secondary sites. SAE rates remained low and stable, with propofol‑associated SAEs occurring in 2.6% of cases. Propofol accounted for 4.9% of all sedations and 20% of sedations among eligible patients.
Conclusions:
Using QI methodology, propofol was feasibly and safely implemented across a multi‑site pediatric ED system. While the overall length of sedation did not change, propofol use within a defined clinical scope was associated with shorter length of sedation and LOS for selected patients, providing a reproducible framework for implementation.
Related Concept Videos
Parenteral Anesthetics: Overview
Stages of General Anesthesia
Inhalational Anesthetics: Overview
Drug Delivery: Enteral Route
Drugs in...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
